Alzheimer

Roche Diagnostics: Globally, up to 75 percent of people living with Alzheimer’s disease have not been diagnosed

The company announces FDA clearance for its Alzheimer’s disease Cerebrospinal Fluid (CSF) assays The Elecsys® Alzheimer’s disease (AD) CSF assays will…

1 year ago

Roche Diagnostics: a nivel mundial, hasta el 75 por ciento de las personas que viven con la enfermedad de Alzheimer no han sido diagnosticadas

La compañía anuncia la aprobación de la FDA para sus ensayos de líquido cefalorraquídeo (LCR) para la enfermedad de Alzheimer…

1 year ago

Researchers at Empa, the Swiss research institute, developed new diagnostic tool that can detect the first signs of neurodegenerative changes using a sensor belt

(PRESS RELEASE) DÜBENDORF, 3-Feb-2022 — /EuropaWire/ — Empa, the Swiss research institute for applied materials sciences and technology, has announced…

2 years ago

Investigadores de Empa, el instituto de investigación suizo, desarrollaron una nueva herramienta de diagnóstico que puede detectar los primeros signos de cambios neurodegenerativos usando un cinturón sensor

(COMUNICADO DE PRENSA) DÜBENDORF, 3-Feb-2022 — /EuropaWire/ — Empa, el instituto de investigación suizo de ciencia y tecnología de materiales…

2 years ago

New study looks into the link between the genetic variant APOE4 allele and the severity of COVID-19 in Finland

(PRESS RELEASE) HELSINKI, 27-Dec-2021 — /EuropaWire/ — University of Helsinki, the oldest and largest institution of academic education in Finland,…

2 years ago

Dementia research: Defects in the geneTREM2 linked to increased risk of Alzheimer’s disease

(PRESS RELEASE) MUNICH, 09-Jan-2019 — /EuropaWire/ — Defects in the geneTREM2 are linked to increased risk of Alzheimer’s disease. The gene…

5 years ago

Innovative therapy in Europe: Functional Neurology to improve life of patients with brain and central nervous system disorders

GENEVA, 08-Jun-2016 — /EuropaWire/ — TESTmyBRAIN (Switzerland) has opened its first center of Functional Neurology in Europe. This non-invasive therapy…

8 years ago

University of Liverpool scientists characterised a genetic mutation that can increase the risk of age-related macular degeneration (AMD) and Alzheimer’s disease

LIVERPOOL, 4-8-2015 — /EuropaWire/ — Scientists at the University of Liverpool have, for the first time, characterised a genetic mutation…

9 years ago

University of Southampton researchers tackle one of the biggest questions in dementia research — Why do Alzheimer’s trials fail?

SOUTHAMPTON, 16-12-2014 — /EuropaWire/ — Researchers in Southampton are tackling one of the biggest questions in dementia research; why might current…

9 years ago